• Reset
Results: 17725 found
LOCATIONS
Asia, Southern
LOCATIONS
Afghanistan
LOCATIONS
Europe
LOCATIONS
Africa, Northern
LOCATIONS
Oceania
LOCATIONS
Africa, Southern
LOCATIONS
Angola
LOCATIONS
America, Central
LOCATIONS
Antigua and Barbuda
LOCATIONS
America, Southern
LOCATIONS
Argentina
LOCATIONS
Australia
LOCATIONS
Austria
LOCATIONS
Bahamas
LOCATIONS
Asia, Western
LOCATIONS
Bangladesh
LOCATIONS
Barbados
LOCATIONS
Belarus
LOCATIONS
Belgium
LOCATIONS
Belize

Country Portfolio of Malaria Research & Investments

LOCATIONS
Africa, Western
LOCATIONS
Benin
LOCATIONS
America, Northern
LOCATIONS
Bermuda
LOCATIONS
Bhutan
LOCATIONS
Bolivia
LOCATIONS
Bosnia and Herzegovina
LOCATIONS
Botswana
LOCATIONS
Brazil
LOCATIONS
Asia, Southeastern
LOCATIONS
Burkina Faso
LOCATIONS
Africa, Eastern
LOCATIONS
Burundi
LOCATIONS
Cabo Verde

Country Portfolio of Malaria Research & Investments

LOCATIONS
Cambodia
LOCATIONS
Africa, Central
LOCATIONS
Cameroon
LOCATIONS
Canada
LOCATIONS
Central African Republic
LOCATIONS
Chad
LOCATIONS
Chile
LOCATIONS
Asia, Eastern
LOCATIONS
China

Country Portfolio of Malaria Research & Investments

LOCATIONS
Colombia
LOCATIONS
Comoros
LOCATIONS
Congo
LOCATIONS
Dem. Rep. of Congo
LOCATIONS
Costa Rica
LOCATIONS
Côte d'Ivoire
LOCATIONS
Croatia
LOCATIONS
Cuba
LOCATIONS
Czechia
LOCATIONS
Denmark
LOCATIONS
Djibouti
LOCATIONS
Dominica
LOCATIONS
Dominican Republic
LOCATIONS
Ecuador
LOCATIONS
Egypt
LOCATIONS
El Salvador

Country Portfolio of Malaria Research & Investments

LOCATIONS
Equatorial Guinea
LOCATIONS
Eritrea
LOCATIONS
Estonia
LOCATIONS
Ethiopia
LOCATIONS
Finland
LOCATIONS
France
LOCATIONS
French Guiana
LOCATIONS
Gabon
LOCATIONS
The Gambia
LOCATIONS
Germany
LOCATIONS
Ghana

Country Portfolio of Malaria Research & Investments

LOCATIONS
Greece

Country Portfolio of Malaria Research & Investments

LOCATIONS
Grenada
LOCATIONS
Guam
LOCATIONS
Guatemala
LOCATIONS
Guinea
LOCATIONS
Guinea-Bissau
LOCATIONS
Guyana
LOCATIONS
Haiti
LOCATIONS
Honduras
LOCATIONS
Hong Kong
LOCATIONS
Hungary
LOCATIONS
India
LOCATIONS
Indonesia
LOCATIONS
Iran
LOCATIONS
Ireland
LOCATIONS
Israel
LOCATIONS
Italy
LOCATIONS
Jamaica
LOCATIONS
Japan
LOCATIONS
Jordan
LOCATIONS
Asia, Central
LOCATIONS
Kazakhstan
LOCATIONS
Kenya

Country Portfolio of Malaria Research & Investments

LOCATIONS
North Korea
LOCATIONS
South Korea
LOCATIONS
Lao PDR
LOCATIONS
Latvia
LOCATIONS
Lebanon
LOCATIONS
Lesotho
LOCATIONS
Liberia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Liechtenstein
LOCATIONS
Lithuania
LOCATIONS
Luxembourg
LOCATIONS
Madagascar
LOCATIONS
Malawi

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malaysia
LOCATIONS
Mali

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malta
LOCATIONS
Mauritania
LOCATIONS
Mauritius

Country Portfolio of Malaria Research & Investments

LOCATIONS
Mexico
LOCATIONS
Morocco
LOCATIONS
Mozambique

Country Portfolio of Malaria Research & Investments

LOCATIONS
Myanmar
LOCATIONS
Namibia
LOCATIONS
Nepal
LOCATIONS
The Netherlands
LOCATIONS
New Zealand
LOCATIONS
Nicaragua
LOCATIONS
Niger
LOCATIONS
Nigeria

Country Portfolio of Malaria Research & Investments

LOCATIONS
Norway
LOCATIONS
Pakistan
LOCATIONS
Panama
LOCATIONS
Papua New Guinea
LOCATIONS
Paraguay

Country Portfolio of Malaria Research & Investments

LOCATIONS
Peru

Country Portfolio of Malaria Research & Investments

LOCATIONS
Philippines
LOCATIONS
Poland
LOCATIONS
Portugal
LOCATIONS
Qatar
LOCATIONS
Réunion

Country Portfolio of Malaria Research & Investments

LOCATIONS
Romania
LOCATIONS
Russian Federation
LOCATIONS
Rwanda

Country Portfolio of Malaria Research & Investments

LOCATIONS
Saint Kitts and Nevis
LOCATIONS
Saint Lucia
LOCATIONS
Saint Vincent and the Grenadines
LOCATIONS
Sao Tome and Principe
LOCATIONS
Saudi Arabia
LOCATIONS
Senegal

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sierra Leone
LOCATIONS
Singapore
LOCATIONS
Slovakia
LOCATIONS
Solomon Islands
LOCATIONS
Somalia
LOCATIONS
South Africa

Country Portfolio of Malaria Research & Investments

LOCATIONS
South Sudan
LOCATIONS
Spain
LOCATIONS
Sri Lanka

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sudan
LOCATIONS
Suriname
LOCATIONS
Eswatini
LOCATIONS
Sweden
LOCATIONS
Switzerland
LOCATIONS
Syria
LOCATIONS
Tajikistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Tanzania

Country Portfolio of Malaria Research & Investments

LOCATIONS
Thailand
LOCATIONS
Togo
LOCATIONS
Trinidad and Tobago
LOCATIONS
Tunisia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Türkiye
Country Portfolio of Malaria Research & Investments
LOCATIONS
Turkmenistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Uganda
LOCATIONS
United Arab Emirates
LOCATIONS
United Kingdom
LOCATIONS
United States
LOCATIONS
Uruguay
LOCATIONS
Vanuatu
LOCATIONS
Venezuela
LOCATIONS
Vietnam
LOCATIONS
Yemen
LOCATIONS
Zambia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Zimbabwe
Projects: 6768 Updates: 1851 Resources: 1288 Institutions: 2619 Principal Investigators: 5071 Deep Dives: 24
Oct 2010 —
Sep 2013
Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period
Liverpool School of Tropical Medicine (LSTM)
Drug-based Strategies | Vulnerable Populations
Apr 2015 —
Aug 2016
Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Cayetano Heredia University (UPCH)
Drug-based Strategies | P. vivax
Oct 2014 —
Dec 2015
Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission (DAPPI)
London School of Hygiene and Tropical Medicine (LSHTM) | Radboud University (RU) Nijmegen
Drug-based Strategies
Jun 2014 —
Jun 2016
Eurartesim in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Swiss Tropical and Public Health Institute (Swiss TPH)
Drug-based Strategies | P. vivax
Oct 2007 —
Aug 2008
Phase Ib Trial of MSP3 LSP in Children in Tanzania
National Institute for Medical Research (NIMR) Tanzania
Vaccines | Vulnerable Populations
Jan 2013 —
Dec 2015

$1.7M

Primaquine’s gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine (PRINOGAM)
Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine
Asymptomatic Reservoir | Drug-based Strategies | Surveillance
Mar 2010 —
Apr 2015
Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon
University of Yaounde 1 (UY1)
Drug-based Strategies | Vulnerable Populations
Feb 2010 —
Dec 2014
Determining the Incidence of New Plasmodium Vivax Infections After Radical Treatment Following Vivax Malaria Along the Thai-Myanmar Border
Mahidol Oxford Tropical Medicine Research Unit (MORU)
Drug-based Strategies | Measurement of Transmission | P. vivax
Oct 2012 —
Dec 2014
Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand
Mahidol University
Drug-based Strategies | P. vivax
Mar 2013 —
Apr 2015
Extended Observation Over a Period of 28 Days of the Effects of Single Doses of OZ439 on the Recrudescence of Plasmodium Falciparum Malaria – a PhIIa, Open Label Study in Adult Patients
Mahidol Oxford Tropical Medicine Research Unit (MORU) | Mahidol University
Drug-based Strategies
Mar 2015 —
Jun 2016
Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria
University of Oxford
Drug Resistance | Drug-based Strategies
Oct 2012 —
Dec 2014
Artesunate-mefloquine vs Chloroquine in patients with acute uncomplicated P. knowlesi and P. vivax malaria: a randomized open label trial in Sabah, Malaysia (ACT KNOW)
Menzies School of Health Research
Drug-based Strategies | P. vivax
Dec 2010 —
Jan 2014
Chloroquine Population Pharmacokinetics in Pre and Post-partum Women (KCP)
Shoklo Malaria Research Unit (SMRU)
Drug-based Strategies | P. vivax | Vulnerable Populations
Aug 2013 —
Jun 2016
Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)
Tulane University
Drug-based Strategies
May 2013 —
Oct 2013

$104,080

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Ifakara Health Institute (IHI)
Drug-based Strategies
Oct 2014 —
Sep 2015
Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
London School of Hygiene and Tropical Medicine (LSHTM)
Drug-based Strategies | Vulnerable Populations
Jan 2014 —
May 2015
School-Based Treatment With ACT to Reduce Transmission (START-IPT)
London School of Hygiene and Tropical Medicine (LSHTM)
Drug-based Strategies | Impact of Interventions | Vulnerable Populations
Nov 2013 —
Mar 2017
Compare the Effectiveness Between Existing Treatment and New Treatment (RDM)
University of Oxford
Drug Resistance | Drug-based Strategies
Oct 2014 —
Apr 2015
MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
Nucleus Network
Drug-based Strategies
Nov 2012 —
Jan 2015
Improving Anti-malarial Treatment Options in Guinea-Bissau – Part A
INDEPTH Network
Drug-based Strategies | Vulnerable Populations
« First
Last »